Back to Search
Start Over
Increased mucosal thrombin is associated with Crohn's disease and causes inflammatory damage through Protease-Activated Receptors activation
- Source :
- Journal of Crohn's and Colitis, Journal of Crohn's and Colitis, Elsevier-Oxford University Press, 2020, ⟨10.1093/ecco-jcc/jjaa229⟩, Journal of Crohn's and Colitis, Elsevier-Oxford University Press, 2021, 15 (5), pp.787-799. ⟨10.1093/ecco-jcc/jjaa229⟩, Journal of Crohn's & Colitis, Journal of Crohn's and Colitis, 2021, 15 (5), pp.787-799. ⟨10.1093/ecco-jcc/jjaa229⟩
- Publication Year :
- 2020
- Publisher :
- HAL CCSD, 2020.
-
Abstract
- BACKGROUND AND AIMS: Thrombin levels in the colon of Crohn's disease patients have recently been found to be elevated 100-fold compared with healthy controls. Our aim was to determine whether and how dysregulated thrombin activity could contribute to local tissue malfunctions associated with Crohn's disease. METHODS: Thrombin activity was studied in tissues from Crohn's disease patients and healthy controls. Intracolonic administration of thrombin to wild-type or protease-activated receptor-deficient mice was used to assess the effects and mechanisms of local thrombin upregulation. Colitis was induced in rats and mice by the intracolonic administration of trinitrobenzene sulphonic acid. RESULTS: Active forms of thrombin were increased in Crohn's disease patient tissues. Elevated thrombin expression and activity were associated with intestinal epithelial cells. Increased thrombin activity and expression were also a feature of experimental colitis in rats. Colonic exposure to doses of active thrombin comparable to what is found in inflammatory bowel disease tissues caused mucosal damage and tissue dysfunctions in mice, through a mechanism involving both protease-activated receptors -1 and -4. Intracolonic administration of the thrombin inhibitor dabigatran, as well as inhibition of protease-activated receptor-1, prevented trinitrobenzene sulphonic acid-induced colitis in rodent models. CONCLUSIONS: Our data demonstrated that increased local thrombin activity, as it occurs in the colon of patients with inflammatory bowel disease, causes mucosal damage and inflammation. Colonic thrombin and protease-activated receptor-1 appear as possible mechanisms involved in mucosal damage and loss of function and therefore represent potential therapeutic targets for treating inflammatory bowel disease. ispartof: JOURNAL OF CROHNS & COLITIS vol:15 issue:5 pages:787-799 ispartof: location:England status: published
- Subjects :
- Male
EXPRESSION
[SDV.MHEP.PHY] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]
Pyridines
colitis
Receptors, Proteinase-Activated
INHIBITION
[SDV.BBM.BM] Life Sciences [q-bio]/Biochemistry, Molecular Biology/Molecular biology
Lactones
Mice
Crohn Disease
MARKERS
[SDV.MHEP.PHY]Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]
Animals
Humans
Rats, Wistar
AcademicSubjects/MED00260
Mice, Inbred BALB C
[SDV.MHEP] Life Sciences [q-bio]/Human health and pathology
Science & Technology
Gastroenterology & Hepatology
Thrombin
protease-activated receptors
[SDV.BBM.BM]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Molecular biology
Original Articles
thrombin
Rats
Up-Regulation
inflammation
Case-Control Studies
barrier
Female
ALPHA-THROMBIN
epithelium
BOWEL DISEASES
Life Sciences & Biomedicine
ELASTASE
SYSTEM
[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
Subjects
Details
- Language :
- English
- ISSN :
- 18739946 and 18764479
- Database :
- OpenAIRE
- Journal :
- Journal of Crohn's and Colitis, Journal of Crohn's and Colitis, Elsevier-Oxford University Press, 2020, ⟨10.1093/ecco-jcc/jjaa229⟩, Journal of Crohn's and Colitis, Elsevier-Oxford University Press, 2021, 15 (5), pp.787-799. ⟨10.1093/ecco-jcc/jjaa229⟩, Journal of Crohn's & Colitis, Journal of Crohn's and Colitis, 2021, 15 (5), pp.787-799. ⟨10.1093/ecco-jcc/jjaa229⟩
- Accession number :
- edsair.pmid.dedup....6e9d26bcf7ad11794fa76d2f02c48061